相关实验视频
Updated: Sep 18, 2025
07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
8.5K
诊断慢性自发性疹有或没有血管的诊断测试:做,不做和也许是
Jonathan A Bernstein1, Ignacio Ansotegui2, Riccardo Asero3
1University of Cincinnati College of Medicine, Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, 231 Albert Sabin Way, ML#563, Cincinnati, OH, 45267-0563 United States.
The World Allergy Organization journal
|June 23, 2025
概括
识别慢性自发性疹 (CSU) 的特定生物标志物可以帮助预测治疗反应. 在开始奥马利祖马布治疗之前,诸如外围乙酸盐和自身抗体之类的测试可以区分CSU亚型.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 过敏 过敏是一种过敏.
背景情况:
- 慢性自发性疹 (CSU) 是一种复杂的疾病,具有不同的内型和表型.
- 通常情况下,急性疹不需要进行常规实验室检测,除非有临床说明.
- 奥马利祖马布的发展增加了人们对识别用于预测治疗反应的生物标志物的兴趣.
研究的目的:
- 审查诊断测试在CSU患者初始评估中的价值.
- 评估生物标志物的实用性,以预测对治疗的反应,特别是奥马利祖马布.
- 探索在CSU中针对非IgE途径的新疗法的需求.
主要方法:
- 对CSU生物标志物的当前数据的审查.
- 分析已建立和新兴的标记物,如外围乙氨基,自身抗体 (抗IgE,抗FcεRIα,抗TPO),总IgE和基基因组胺释放试验.
- 检查这些标记物在区分CSU亚型中的作用 (第一型自身免疫与第一型自身免疫). 2b型自身免疫性疾病).
主要成果:
- 对TPO的外围乙素,自身抗体,总IgE和IgG自身抗体显示出区分自身免疫CSU亚型的潜力.
- 这些标记物正在临床试验中被探索为探索性终点,以确定对新疗法的响应者.
- 目前的数据并不完全确,需要进一步的研究.
结论:
- 诊断测试可能有助于区分CSU亚型,并预测治疗反应,特别是在开始使用奥马利祖马布之前.
- 需要进一步的随机控制和现实世界研究来确认这些测试对基于证据的指导方针的有用性.
- 针对非IgE途径的新疗法对于那些对当前指南推的治疗不反应的患者来说是必要的.
相关概念视频
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
71
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
71
01:30Acute Coronary Syndrome III: Diagnostic Studies
26
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
26
02:06Allergic Reactions
29.0K
Overview
29.0K
01:21Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
39
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
39
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
209
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
209
01:15Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K